Clinical Trial Update: Single-dose, Dose-escalation Study of Safety, PK, and Preliminary Efficacy of XOMA 052 in Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase 1 single-dose, dose-escalation study evaluating safety, pharmacokinetics, and preliminary efficacy of XOMA 052 in Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• XOMA 052

Snippet

Sponsor: XOMA (US) LLC | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED